1. Integration of modeling and simulation to support changes to ondansetron dosing following a randomized, double‐blind, placebo‐, and active‐controlled thorough QT study. (6th May 2014) Authors: Zuo, Peiying; Haberer, Lynda J.; Fang, Lei; Hunt, Thomas L.; Ridgway, Derry; Russo, Mark W. Journal: Journal of clinical pharmacology Issue: Volume 54:Number 11(2014:Nov.) Page Start: 1221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Population Pharmacokinetic/Pharmacodynamic Analysis of Intravenous Zanamivir in Healthy Adults and Hospitalized Adult and Pediatric Subjects With Influenza. Issue 1 (7th November 2019) Authors: Zuo, Peiying; Collins, Jon; Okour, Malek; Barth, Aline; Shortino, Denise; Yates, Phillip; Roberts, Grace; Watson, Helen A.; Peppercorn, Amanda; Hossain, Mohammad Journal: Clinical and translational science Issue: Volume 13:Issue 1(2020) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Risk‐Based Pharmacokinetic and Drug–Drug Interaction Characterization of Antibody–Drug Conjugates in Oncology Clinical Development: An International Consortium for Innovation and Quality in Pharmaceutical Development Perspective. Issue 4 (23rd November 2021) Authors: Li, Chunze; Menon, Rajeev; Walles, Markus; Singh, Renu; Upreti, Vijay V.; Brackman, Deanna; Lee, Anthony J.; Endres, Christopher J.; Kumar, Seema; Zhang, Donglu; Barletta, Frank; Suri, Ajit; Hainzl, Dominik; Liao, Kai H.; Lalovic, Bojan; Beaumont, Maribel; Zuo, Peiying; Mayer, Andrew P.; Wei... Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 4(2022) Page Start: 754 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗